Position in JNJ
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$48,596,904
+$4,456,908 QoQ
Shares Held
191,349
+6.0% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
1.79%
of 13F equity value
Holder Rank
#450
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Argent Trust Co holds $201,801,045 across 13 Drug Manufacturers - General names. JNJ ranks #2 (24.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
198,148 | $49,861,961 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
191,349 | $48,596,904 | |
| 3 | LLY |
ELI LILLY & Co
|
29,355 | $35,209,269 | |
| 4 | MRK |
Merck & Co., Inc.
|
204,960 | $26,337,359 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
86,362 | $10,910,974 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
134,450 | $7,747,007 | |
| 7 | AMGN |
Amgen Inc
|
20,391 | $7,383,988 | |
| 8 | NVS |
Novartis AG
|
39,948 | $6,260,649 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $48,596,904 | 191,349 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $44,139,996 | 180,576 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $37,169,874 | 179,608 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $33,614,790 | 181,290 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $27,027,737 | 176,941 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $28,833,107 | 173,861 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $24,918,603 | 172,304 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $27,812,411 | 171,618 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $27,711,204 | 189,595 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $29,839,695 | 188,632 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $30,124,642 | 192,195 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $29,082,262 | 186,724 | Shares | Defined | 2023-11-08 | |
| 2023-06-30 | $30,484,975 | 184,177 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $26,352,325 | 170,015 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $29,249,705 | 165,580 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $26,777,807 | 163,919 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $28,643,722 | 161,364 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $28,226,003 | 159,262 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $27,262,227 | 159,363 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $25,655,889 | 158,860 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $25,197,641 | 152,954 | Shares | Defined | 2021-08-09 | |
| 2021-03-31 | $24,744,534 | 150,560 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $22,819,154 | 144,994 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $20,545,439 | 138,000 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $19,033,004 | 135,341 | Shares | Defined | 2020-08-04 | |
| 2020-03-31 | $16,948,026 | 129,246 | Shares | Defined | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||